NASDAQ:ONTF
ON24, Inc. Stock News
$6.40
-0.140 (-2.14%)
At Close: May 17, 2024
ON24 (ONTF) Upgraded to Buy: Here's What You Should Know
01:32pm, Tuesday, 27'th Dec 2022
ON24 (ONTF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Indaba Capital Discloses 8.8% ON24 Stake and Plans to Discuss Ways to Improve Share Price With the Board
10:16pm, Wednesday, 21'st Dec 2022
Fintel reports that today, activist hedge fund Indaba Capital Management, L.P.
ON24, Inc. (ONTF) Q3 2022 Earnings Call Transcript
09:44pm, Wednesday, 09'th Nov 2022
ON24, Inc. (NYSE:ONTF ) Q3 2022 Earnings Conference Call November 9, 2022 5:00 PM ET Company Participants Lori Barker - Investor Relations Sharat Sharan - Co-Founder, President and Chief Executive Off
ON24 (ONTF) Reports Q3 Loss, Tops Revenue Estimates
09:04pm, Wednesday, 09'th Nov 2022
ON24 (ONTF) delivered earnings and revenue surprises of 56.25% and 0.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ON24, Inc. (ONTF) CEO Sharat Sharan on Q2 2022 Results - Earnings Call Transcript
10:54pm, Tuesday, 09'th Aug 2022
ON24, Inc. (NYSE:ONTF ) Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Lori Barker - Investor Relations Sharat Sharan - Co-Founder, Chief Executive Officer, President
ON24 (ONTF) Reports Q2 Loss, Tops Revenue Estimates
09:49pm, Tuesday, 09'th Aug 2022
ON24 (ONTF) delivered earnings and revenue surprises of 12.50% and 1.82%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ON24 Announces Date for Second Quarter 2022 Earnings Release and Conference Call
04:15pm, Wednesday, 13'th Jul 2022
SAN FRANCISCO--(BUSINESS WIRE)--ON24 (NYSE: ONTF) will release its second quarter 2022 financial results after U.S. markets close on Tuesday, August 9, 2022. ON24 management will host a conference cal
ON24, Inc. (ONTF) CEO Sharat Sharan on Q1 2022 Results - Earnings Call Transcript
03:21am, Wednesday, 11'th May 2022
ON24, Inc. (NYSE:ONTF ) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Lauren Sloane - The Blueshirt Group Sharat Sharan - Founder, CEO, President & Chair Steven Vattuon
ON24 (ONTF) Reports Q1 Loss, Tops Revenue Estimates
08:19pm, Tuesday, 10'th May 2022
ON24 (ONTF) delivered earnings and revenue surprises of 18.75% and 2.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ON24 Announces Date for First Quarter 2022 Earnings Release and Conference Call
04:15pm, Tuesday, 12'th Apr 2022
SAN FRANCISCO--(BUSINESS WIRE)--ON24 (NYSE: ONTF) will release its first quarter 2022 financial results after U.S. markets close on Tuesday, May 10, 2022. ON24 management will host a conference call a
ON24 Pursues 2022 Growth Plans Amid Customer Churn Risks
06:36pm, Thursday, 10'th Mar 2022 Seeking AlphaWhere ON24 Stands With Analysts
09:01pm, Tuesday, 01'st Mar 2022 Benzinga
ON24 (NYSE: ONTF ) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 2 0 0 Last 30D 0 1 2 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 0 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, ON24 has an average price target of $19.75 with a high of $24.00 and a low of $17.00. Below is a summary of how these 4 analysts rated ON24 over the past 3 months. The greater the number of bullish ratings, the more positive analysts … Full story available on Benzinga.com
Benzinga''s Top Ratings Upgrades, Downgrades For March 1, 2022
03:04pm, Tuesday, 01'st Mar 2022 Benzinga
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ: RVMD ) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of $50.88 and a 52-week-low of $18.07. At the end of the last trading period, Revolution Medicines closed at $18.92. According to UBS, the prior rating for Amedisys Inc (NASDAQ: AMED ) was changed from Sell to Neutral. For the fourth quarter, Amedisys had an EPS of $1.18, compared to year-ago quarter EPS of $1.49. At the moment, the stock has a 52-week-high of $292.97 and a 52-week-low of $122.12. Amedisys closed at $160.24 at the end of the last trading period. For Sunstone Hotel Investors Inc (NYSE: SHO ), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. At the moment, the stock has a 52-week-high of $13.91 and a 52-week-low of $9.93. Sunstone Hotel Invts closed at $10.58 at the end of the last trading period. Wedbush upgraded the previous rating for Logitech International SA (NASDAQ: LOGI ) from Neutral to Outperform.
ON24, Inc. (ONTF) CEO Sahat Sharan on Q4 2021 Results - Earnings Call Transcript
03:22am, Tuesday, 01'st Mar 2022 Seeking AlphaON24 Inc. CEO says Q1 is trough, sees steady improvement after
02:57am, Tuesday, 01'st Mar 2022 Seeking Alpha
ON24 Inc. (ONTF) CEO Sharat Sharan said the company''s Q1 will be the "trough" and he expects improvements going forward."Q1 is the trough and after that we expect to see…